These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2939691)

  • 21. Zimeldine to geriatric patients in once daily dosage. A pharmacokinetic and clinical study.
    Dehlin O; Björnson G; Lundström J; Nörgård J
    Acta Psychiatr Scand; 1984 Feb; 69(2):103-11. PubMed ID: 6230881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between EEG and biochemical parameters in major depressive disorder.
    Nyström C; Matousek M; Hällström T
    Acta Psychiatr Scand; 1988 Apr; 77(4):457-62. PubMed ID: 3389183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of maprotiline and chlorimipramine: controlled study.
    Montejo-Iglesias ML; Ramos-Brieva JA
    Neuropsychobiology; 1988; 19(1):20-4. PubMed ID: 3054622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
    Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
    Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
    Bengtsson BO; Lundmark J; Wålinder J
    Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHPG as a predictor of antidepressant response to imipramine and maprotiline.
    Rosenbaum AH; Schatzberg AF; Maruta T; Orsulak PJ; Cole JO; Grab EL; Schildkraut JJ
    Am J Psychiatry; 1980 Sep; 137(9):1090-2. PubMed ID: 7425162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment.
    Lingjaerde O
    J Clin Psychopharmacol; 1984 Apr; 4(2):76-81. PubMed ID: 6231316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EEG assessment of the sedative and excitatory properties of CNS-active compounds in the patients with depression.
    Matousek M
    Neuropsychobiology; 1987; 17(1-2):118-20. PubMed ID: 2957608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homoallylic amines related to zimeldine. A comparative study on neuronal serotonin and norepinephrine reuptake based on conformational analysis.
    Högberg T; Ross SB; Ström P; Grunewald GL; Creese MW; Bunce JD
    J Med Chem; 1988 May; 31(5):913-9. PubMed ID: 2966246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The antidepressive maprotiline: symposium at Hradec Kralove 26 November 1980].
    Act Nerv Super (Praha); 1982 May; 24(2):39-118. PubMed ID: 7102224
    [No Abstract]   [Full Text] [Related]  

  • 35. The new antidepressant zimeldine in general practice. A surveillance study of 15,000 patients.
    Fünfgeld EW
    Acta Psychiatr Scand Suppl; 1983; 308():96-103. PubMed ID: 6230899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological specificity is not the same as clinical selectivity.
    Montgomery SA; James D; Montgomery DB
    Psychopharmacol Ser; 1987; 3():179-83. PubMed ID: 2434946
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of maprotiline in treatment of cardiac patients with left anterior hemiblock.
    Ghadirian AM; Ananth J
    Psychiatr J Univ Ott; 1989 Sep; 14(3):476-7. PubMed ID: 2678191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment.
    Corona GL; Cucchi ML; Santagostino G; Frattini P; Zerbi F; Fenoglio L; Savoldi F
    Psychopharmacology (Berl); 1982; 77(3):236-41. PubMed ID: 6812145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

  • 40. Maprotiline in pain-depression.
    Lindsay PG; Olsen RB
    J Clin Psychiatry; 1985 Jun; 46(6):226-8. PubMed ID: 3888970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.